Serrapeptase
SupplementProteolytic enzyme supplement
Also known as: serratiopeptidase, Serratiopeptidase, Serrapeptase (JAN), Serrapeptasum (INN-Latin), Serrapeptasa (INN-Spanish), Dasen, serrapeptasi, Aniflazime
A real evidence base, with gaps
- Regulatory standing. Sold as a supplement, not an approved drug
- Limited human data. Some human data exists, not conclusive
- Registered human trials. 8 registered studies on ClinicalTrials.gov, most advanced Phase 4
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Serrapeptase, also called serratiopeptidase, is a protein-digesting enzyme originally isolated from Serratia bacteria and sold in the US as a dietary supplement. It is thought to break down proteins involved in inflammation and mucus, though how much of an orally taken enzyme survives digestion and reaches the bloodstream in active form is debated.
What the evidence shows
It is not FDA approved for any use, and the human evidence is limited to a small number of trials (8 registered) and about 32 published papers, many small or of modest quality, with reviews describing the case for anti-inflammatory or pain benefits as unproven. The listed PubChem formula does not match a large enzyme, so that database entry may be unreliable.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
A Comparison of Recovery After Impacted Wisdom Tooth Removal
Effectiveness of Serratiopeptidase After Mandibular Third Molar Surgery
Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study
The Effect of Supplementary Foods Containing Trypsin, Chymotrypsin and Serratia Peptidase on Healing After Impacted Wisdom Tooth Surgery
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars.
Serrapeptase and nattokinase intervention for relieving Alzheimer's disease pathophysiology in rat model.
Potential use of targeted enzymatic agents in the treatment of Staphylococcus aureus biofilm-related infections.
Enzyme-Functionalized Mesoporous Silica Nanoparticles to Target <i>Staphylococcus aureus</i> and Disperse Biofilms.
Sources
- PubChem compound record (CID 171666295)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.